Image 01
Prograf Capsule, Gelatin Coated
Product Images NDC 0469-0657
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Prograf (NDC 0469-0657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Image 03
Image 04
Image 05
Image 06
Image 07
Image 08
This text is a list of items that includes a container of drinking water, a carton of packets of a substance named Prograf, a glass cup, a measuring device, scissors, a metal stirring spoon, and a paper towel. There is no further information available in this text.*
Image 09
Image 10
Image 11
Image 12
Image 13
Image 14
Image 15
This appears to be a list of various items included in a container. The contents include drinking water, a plunger, oral medication in a carton of packets, a syringe, a glass cup, a measuring device, scissors, a metal stirring spoon, and a paper towel. It is unclear what the container is intended for.*
Image 16
Image 17
Image 18
Image 19
Image 20
Image 21
Image 22
Image 23
Prograf (tacrolimus) capsules are a prescription medication that come in a pack of 100 capsules, produced in Japan, by Astellas Ireland Co., Ltd. It is marketed by Astellas Pharma US, Inc. Prograf capsules contain 0.5mg of Tacrolimus along with lactose, hydroxypropyl methylcellulose 2910, croscarmellose sodium, and magnesium stearate inside them. The capsules should be stored at a temperature of 25°C (77°F) with excursions allowed between 15°C-30°C (59°F-86°F). For more detailed dosage information please see the package insert.*
Image 24
Prograf capsules contain Tacrolimus and are used to suppress the immune system after organ transplant surgery. These capsules are manufactured by Astellas Ireland Co., Ltd. in Japan and marketed by Astellas Pharma US, Inc. in Northbrook, Illinois. Each hard gelatin capsule contains 1 mg of Tacrolimus, along with lactose, hydroxypropyl methylcellulose 2910, croscarmellose sodium and magnesium stearate as inactive ingredients. The recommended storage temperature for the capsules is 25°C (77°F), with excursions allowed between 15°C-30°C (59°F-86°F). It is advised to refer to the package insert for dosage information.*
Image 25
Prograf (tacrolimus) capsules are a medication with the active ingredient Tacrolimus. It comes in a pack of 100 capsules by Astellas Ireland Co., Ltd. and sold by Astellas Pharma US, Inc. The recommended storage is between 15°C to 30°C. It is a prescription drug that must be taken as per dosage information provided in the package insert. The capsules are made of lactose, hydroxypropyl methylcellulose 2910, croscarmellose sodium, and magnesium stearate in a hard gelatin capsule.*
Image 26
Prograf® (tacrolimus) is a sterile injectable solution for intravenous use only after dilution. It is available in 10 (1 mL) ampules containing 5 mg of Tacrolimus, a drug used to prevent organ transplant rejection. The solution also contains Polyoxyl 60 Hydrogenated Castor Oil and Dehydrated Alcohol. Dosage information can be found in the package insert. The solution should be stored between 5°C and 25°C (41°F- 77°F). Prograf® is a registered trademark of Astellas Pharma Inc.*
Image 27
This is a label for the drug Prograf® Granules, containing tacrolimus for oral suspension. The label provides information for mixing and preparing the medication to be taken. The dosage information is available on the prescribing information. The medication should be kept away from children. The label also includes a 2D barcode and variable code area, and it contains 50 unit-dose packets.*
Image 28
This is a label of a medication called Prograf®Granules, containing Tacrolimus, for oral suspension. The label provides instructions on how to mix and prepare the granules, dosage information, and a warning to keep it out of the reach of children. The label also includes a variable code area and a 2D barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
